Nectar Lifesciences informs about standalone financial results

23 Aug 2016 Evaluate

Nectar Lifesciences has informed about Standalone Financial Results, Limited Review for the period ended June 30, 2016.

The above information is a part of company’s filings submitted to BSE.

Nectar Lifesciences Share Price

21.90 -0.74 (-3.27%)
11-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1687.55
Dr. Reddys Lab 1109.15
Cipla 1463.15
Lupin 1969.05
Zydus Lifesciences 868.25
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...